Business
Admission to Trading
GSK plc has announced the admission of 96,525 ordinary shares of 31¼ pence each to trading on the London Stock Exchange's Main Market. These shares, admitted under existing block listing arrangements for the GlaxoSmithKline plc Share Save Plans 2012 and 2022, are fully fungible with the company's existing ordinary shares. Following this admission, the total number of ordinary shares admitted to trading stands at 4,316,176,278. This notification covers the period from 23 January 2026 to 20 March 2026. Disclaimer*
About this update from Gsk Plc
[{"type":"text","content":"\n\nIssued: 23 March 2026, London UK\n \nAdmission to trading\n \n \n\nIn conformity with PRM 1.6.4R, GSK plc notifies the market that ordinary shares of 31¼ pence each ('Ordinary Shares') have been admitted to trading as set out in the table below. The Ordinary Shares have been admitted to trading under existing block listing admissions of Ordinary Shares in connection with the \"GlaxoSmithKline plc Share Save Plan 2012 and 2022\".\n \n \n\n\n\n\n1a\n\n\nIssuer name\n \n\n\nGSK plc\n\n\n\n\n1b\n\n\nIssuer LEI\n \n\n\n5493000HZTVUYLO1D793\n\n\n\n\n2\n\n\nRegulated market on which the securities have been admitted to trading\n \n\n\nLondon Stock Exchange - Main Market\n\n\n\n\n3\n\n\nName, type and ISIN of the securities\n\n\nOrdinary Shares of 31¼ pence each\n \nISIN: GB00BN7SWP63\n \n\n\n\n\n4\n\n\nNumber of further securities admitted to trading covered by this notification\n \n\n\n96,525\n\n\n\n\n5\n\n\nTotal number of securities admitted to trading following admission\n \n\n\n4,316,176,278\n\n\n\n\n6\n\n\nFungibility\n \n\n\nFully fungible with existing Ordinary Shares\n\n\n\n\n7\n\n\nDate range covered by the notification\n\n\n23 January 2026 - 20 March 2026\n \n\n\n\n\n8\n\n\nProspectus information\n\n\nN/A\n \n\n\n\n\n \n \nV A Whyte\nCompany Secretary\n \n23 March 2026\n \n \nAbout GSK\nGSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together. Find out more at www.gsk.com.\n \nRegistered in England & Wales:\nNo. 3888792\n \nRegistered Office:\n79 New Oxford Street\nLondon\nWC1A 1DG\n \n \n\n","length":6445,"tagName":"div"}]